{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:08:04Z","timestamp":1793495284946,"version":"4.5.0"},"reference-count":133,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:p>Dengue is the disease caused by 1 of 4 distinct, but closely related dengue viruses (DENV-1\u20134) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral disease worldwide, with the greatest burden in tropical and sub-tropical regions. In the absence of effective prevention and control measures, dengue is projected to increase in both disease burden and geographic range. Given its increasing importance as an etiology of fever in the returning traveler or the possibility of local transmission in regions in the United States with competent vectors, as well as the risk for large outbreaks in endemic US territories and associated states, clinicians should understand its clinical presentation and be familiar with appropriate testing, triage, and management of patients with dengue. Control and prevention efforts reached a milestone in June 2021 when the Advisory Committee on Immunization Practices (ACIP) recommended Dengvaxia for routine use in children aged 9 to 16 years living in endemic areas with laboratory confirmation of previous dengue virus infection. Dengvaxia is the first vaccine against dengue to be recommended for use in the United States and one of the first to require laboratory testing of potential recipients to be eligible for vaccination. In this review, we outline dengue pathogenesis, epidemiology, and key clinical features for front-line clinicians evaluating patients presenting with dengue. We also provide a summary of Dengvaxia efficacy, safety, and considerations for use as well as an overview of other potential new tools to control and prevent the growing threat of dengue.<\/jats:p>","DOI":"10.1542\/peds.2021-055522","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T04:08:41Z","timestamp":1652242121000},"source":"Crossref","is-referenced-by-count":103,"title":["Dengue: A Growing Problem With New Interventions"],"prefix":"10.1542","volume":"149","author":[{"given":"Joshua M.","family":"Wong","sequence":"first","affiliation":[{"name":"aEpidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia;"},{"name":"bDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Adams","sequence":"additional","affiliation":[{"name":"bDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Durbin","sequence":"additional","affiliation":[{"name":"cCenter for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Mu\u00f1oz-Jord\u00e1n","sequence":"additional","affiliation":[{"name":"bDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Poehling","sequence":"additional","affiliation":[{"name":"dWake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana M.","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"bDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Volkman","sequence":"additional","affiliation":[{"name":"bDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Paz-Bailey","sequence":"additional","affiliation":[{"name":"bDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"issue":"7446","key":"2023110714264881900_B1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"9","key":"2023110714264881900_B2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"issue":"8","key":"2023110714264881900_B3","doi-asserted-by":"crossref","first-page":"taab146","DOI":"10.1093\/jtm\/taab146","article-title":"Global burden for dengue and the evolving pattern in the past 30 years","volume":"28","author":"Yang","year":"2021","journal-title":"J Travel Med"},{"issue":"1","key":"2023110714264881900_B4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4269\/ajtmh.2010.09-0346","article-title":"The epidemiology of dengue in the americas over the last three decades: a worrisome reality","volume":"82","author":"San Mart\u00edn","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"2023110714264881900_B5","unstructured":"Pan American Health Organization\n          . Dengue. Available at: https:\/\/www.paho.org\/data\/index.php\/en\/mnu-topics\/indicadores- dengue-en.html. Accessed October 12, 2021"},{"issue":"10215","key":"2023110714264881900_B6","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(19)32531-0","article-title":"Dengue in the Americas: Honduras\u2019 worst outbreak","volume":"394","author":"Dos Santos","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"2023110714264881900_B7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11908-018-0656-3","article-title":"Risk of dengue in travelers: implications for dengue vaccination","volume":"20","author":"Wilder-Smith","year":"2018","journal-title":"Curr Infect Dis Rep"},{"issue":"7","key":"2023110714264881900_B8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3201\/eid1407.071412","article-title":"Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006","volume":"14","author":"Schwartz","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"2023110714264881900_B9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3201\/eid2302.160751","article-title":"Genetic diversity and new lineages of dengue virus serotypes 3 and 4 in returning travelers, Germany, 2006-2015","volume":"23","author":"Shihada","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2023110714264881900_B10","doi-asserted-by":"crossref","first-page":"108226","DOI":"10.1016\/j.celrep.2020.108226","article-title":"Antigenic variation of the dengue virus 2 genotypes impacts the neutralization activity of human antibodies in vaccinees","volume":"33","author":"Martinez","year":"2020","journal-title":"Cell Rep"},{"issue":"6","key":"2023110714264881900_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7006a1","article-title":"Dengue vaccine: recommendations of the advisory committee on immunization practices, United States, 2021","volume":"70","author":"Paz-Bailey","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"2023110714264881900_B12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3201\/eid2508.190089","article-title":"Lessons learned from dengue surveillance and research, Puerto Rico, 1899-2013","volume":"25","author":"Sharp","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"2023110714264881900_B13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15585\/mmwr.mm6906a1","article-title":"Travel-associated and locally acquired dengue cases - United States, 2010-2017","volume":"69","author":"Rivera","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023110714264881900_B14","unstructured":"Centers for Disease Control and Prevention NCfEaZIDN\n          . Division of vector-borne diseases (DVBD), dengue: statistics and maps. Available at: https:\/\/www.cdc.gov\/dengue\/statistics-maps\/index.html. Accessed October 18, 2021"},{"issue":"6","key":"2023110714264881900_B15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/jme\/tjx163","article-title":"Modeling the environmental suitability for Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictus (Diptera: Culicidae) in the contiguous United States","volume":"54","author":"Johnson","year":"2017","journal-title":"J Med Entomol"},{"issue":"6","key":"2023110714264881900_B16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3201\/eid2206.152000","article-title":"Reemergence of dengue in southern Texas, 2013","volume":"22","author":"Thomas","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2023110714264881900_B17","doi-asserted-by":"crossref","first-page":"e08347","DOI":"10.7554\/eLife.08347","article-title":"The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus","volume":"4","author":"Kraemer","year":"2015","journal-title":"eLife"},{"issue":"10","key":"2023110714264881900_B18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3201\/eid1310.061586","article-title":"Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004","volume":"13","author":"Brunkard","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2023110714264881900_B19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4269\/ajtmh.2008.78.364","article-title":"Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005","volume":"78","author":"Ramos","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"1665","key":"2023110714264881900_B20","doi-asserted-by":"crossref","first-page":"20140135","DOI":"10.1098\/rstb.2014.0135","article-title":"Climate change influences on global distributions of dengue and chikungunya virus vectors","volume":"370","author":"Campbell","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"12","key":"2023110714264881900_B21","doi-asserted-by":"crossref","first-page":"e1378","DOI":"10.1371\/journal.pntd.0001378","article-title":"Population dynamics of Aedes aegypti and dengue as influenced by weather and human behavior in San Juan, Puerto Rico","volume":"5","author":"Barrera","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2023110714264881900_B22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40572-021-00322-8","article-title":"A review of dengue\u2019s historical and future health risk from a changing climate","volume":"8","author":"Soneja","year":"2021","journal-title":"Curr Environ Health Rep"},{"issue":"1","key":"2023110714264881900_B23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40249-018-0475-7","article-title":"Scoping review on vector-borne diseases in urban areas: transmission dynamics, vectorial capacity and co-infection","volume":"7","author":"Eder","year":"2018","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2023110714264881900_B24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid0901.020220","article-title":"Texas lifestyle limits transmission of dengue virus","volume":"9","author":"Reiter","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2023110714264881900_B25","doi-asserted-by":"crossref","first-page":"105066","DOI":"10.1016\/j.actatropica.2019.105066","article-title":"Impact of population displacement and forced movements on the transmission and outbreaks of Aedes-borne viral diseases: dengue as a model","volume":"197","author":"Abdul-Ghani","year":"2019","journal-title":"Acta Trop"},{"key":"2023110714264881900_B26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2149\/tmh.2011-S05","article-title":"Dengue, urbanization and globalization: the unholy trinity of the 21(st) Century","volume":"39","author":"Gubler","year":"2011","journal-title":"Trop Med Health"},{"issue":"9","key":"2023110714264881900_B27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-3156.2002.00930.x","article-title":"Dynamics of dengue virus circulation: a silent epidemic in a complex urban area","volume":"7","author":"Teixeira","year":"2002","journal-title":"Trop Med Int Health"},{"issue":"3","key":"2023110714264881900_B28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"2023110714264881900_B29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.actatropica.2014.04.024","article-title":"Spatio-temporal dynamics of dengue 2009 outbreak in C\u00f3rdoba City, Argentina","volume":"136","author":"Estallo","year":"2014","journal-title":"Acta Trop"},{"issue":"10169","key":"2023110714264881900_B30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"issue":"15","key":"2023110714264881900_B31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2023110714264881900_B32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4269\/ajtmh.14-0132","article-title":"Review article: research on dengue during World War II revisited","volume":"91","author":"Snow","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2023110714264881900_B33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"2023110714264881900_B34","doi-asserted-by":"crossref","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","article-title":"Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year","volume":"7","author":"Montoya","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2023110714264881900_B35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/jit436","article-title":"A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand","volume":"209","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"issue":"5","key":"2023110714264881900_B36","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"issue":"2","key":"2023110714264881900_B37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"2023110714264881900_B38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2023110714264881900_B39","doi-asserted-by":"crossref","first-page":"e01998-20","DOI":"10.1128\/JVI.01998-20","article-title":"The internal ribosome entry site of the Dengue virus mRNA is active when cap-dependent translation initiation is inhibited","volume":"95","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"J Virol"},{"key":"2023110714264881900_B40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virol.2015.05.017","article-title":"Dengue virus NS1 protein interacts with the ribosomal protein RPL18: this interaction is required for viral translation and replication in Huh-7 cells","volume":"484","author":"Cervantes-Salazar","year":"2015","journal-title":"Virology"},{"issue":"1","key":"2023110714264881900_B41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis","volume":"5","author":"Glasner","year":"2018","journal-title":"Annu Rev Virol"},{"issue":"10","key":"2023110714264881900_B42","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1172\/JCI131170","article-title":"Dengue vascular leak syndrome: insights into potentially new treatment modalities","volume":"129","author":"Durbin","year":"2019","journal-title":"J Clin Invest"},{"issue":"22","key":"2023110714264881900_B43","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2023110714264881900_B44","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J Immunol"},{"issue":"6365","key":"2023110714264881900_B45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"issue":"36","key":"2023110714264881900_B46","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.vaccine.2017.07.045","article-title":"Immune correlates of protection for dengue: state of the art and research agenda","volume":"35","author":"Katzelnick","year":"2017","journal-title":"Vaccine"},{"issue":"6507","key":"2023110714264881900_B47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"issue":"11","key":"2023110714264881900_B48","doi-asserted-by":"crossref","first-page":"e1002181","DOI":"10.1371\/journal.pmed.1002181","article-title":"The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study","volume":"13","author":"Flasche","year":"2016","journal-title":"PLoS Med"},{"issue":"2","key":"2023110714264881900_B49","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1473-3099(20)30871-9","article-title":"Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluation","volume":"22","author":"Sharp","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023110714264881900_B50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections","volume":"5","author":"Grange","year":"2014","journal-title":"Front Immunol"},{"key":"2023110714264881900_B51","unstructured":"Centers for Disease Control and Prevention\n          . Dengue clinical case management clinician pocket guide. Available at: https:\/\/www.cdc.gov\/dengue\/resources\/DengueCheatSheet_ENG-P.pdf. Accessed November 8, 2021"},{"key":"2023110714264881900_B52","volume-title":"Algorithms for the Clinical Management of Dengue Patients","author":"Regional Arboviral Disease Program","year":"2020"},{"key":"2023110714264881900_B53","volume-title":"CDC Yellow Book 2020: Health Information for International Travel","author":"Centers for Disease Control and Prevention","year":"2017"},{"issue":"9","key":"2023110714264881900_B54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa044057","article-title":"Comparison of three fluid solutions for resuscitation in dengue shock syndrome","volume":"353","author":"Wills","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"2023110714264881900_B55","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/cid\/cit594","article-title":"Clinical characteristics of dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital","volume":"57","author":"Lam","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2023110714264881900_B56","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1371\/journal.pntd.0002311","article-title":"Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus","volume":"7","author":"Santiago","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2023110714264881900_B57","unstructured":"Centers for Disease Control and Prevention\n          . Dengue for Healthcare Providers: Testing Guidance. Available at: https:\/\/www.cdc.gov\/dengue\/healthcare- providers\/testing\/testing-guidance.html. Accessed June 30, 2021"},{"issue":"6","key":"2023110714264881900_B58","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/infdis\/jiw103","article-title":"Performance of dengue diagnostic tests in a single-specimen diagnostic algorithm","volume":"214","author":"Hunsperger","year":"2016","journal-title":"J Infect Dis"},{"key":"2023110714264881900_B59","doi-asserted-by":"crossref","first-page":"S951","DOI":"10.1093\/infdis\/jix502","article-title":"Diagnosis of Zika virus infections: challenges and opportunities","volume":"216","author":"Munoz-Jordan","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"2023110714264881900_B60","first-page":"e01115","article-title":"Ability to serologically confirm recent Zika virus infection in areas with varying past incidence of dengue virus infection in the United States and US territories in 2016","volume":"56","author":"Lindsey","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2023110714264881900_B61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6801a1","article-title":"Dengue and Zika virus diagnostic testing for patients with a clinically compatible illness and risk for infection with both viruses","volume":"68","author":"Sharp","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"2023110714264881900_B62","unstructured":"Food and Drug Administration\n          \n          K100534 InBios DENV detect IgM capture ELISA; evaluation of automatic class III designation. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/K100534.pdf. Accessed November 1, 2021"},{"key":"2023110714264881900_B63","article-title":"510(k) substantial equivalence determination decision summary; K181473 InBios dengue virus NS1 antigen","author":"Food and Drug Administration (FDA)","year":"2018"},{"issue":"7","key":"2023110714264881900_B64","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/infdis\/jix678","article-title":"Innovative and new approaches to laboratory diagnosis of Zika and dengue: a meeting report","volume":"217","author":"Goncalves","year":"2018","journal-title":"J Infect Dis"},{"issue":"8","key":"2023110714264881900_B65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/v12080829","article-title":"Dengue: a minireview","volume":"12","author":"Harapan","year":"2020","journal-title":"Viruses"},{"key":"2023110714264881900_B66","unstructured":"Centers for Disease Control and Prevention\n          . Dengue Case Management. Available at: https:\/\/www.cdc.gov\/dengue\/resources\/dengue-clinician-guide_508.pdf. Accessed October 21, 2021"},{"issue":"10","key":"2023110714264881900_B67","doi-asserted-by":"crossref","first-page":"e0183544","DOI":"10.1371\/journal.pone.0183544","article-title":"Effectiveness of a fluid chart in outpatient management of suspected dengue fever: a pilot study","volume":"12","author":"Nasir","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"2023110714264881900_B68","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3201\/eid0908.020456","article-title":"Fluid intake and decreased risk for hospitalization for dengue fever, Nicaragua","volume":"9","author":"Harris","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2023110714264881900_B69","unstructured":"Pan American Health Organization (PAHO)\n          . Self-learning course: clinical diagnosis and management of dengue (2021). Available at: https:\/\/www.campusvirtualsp.org\/en\/course\/self- learning-course-clinical-diagnosis-and- management-dengue-2021. Accessed November 1, 2021"},{"issue":"1","key":"2023110714264881900_B70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14787210.2017.1248405","article-title":"Current management of severe dengue infection","volume":"15","author":"Lee","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"2023110714264881900_B71","first-page":"CD000567","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill people","volume":"8","author":"Lewis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2023110714264881900_B72","volume-title":"Dengue: Guidelines for Patient Care in the Region of the Americas","author":"Pan American Health Organization","year":"2016","edition":"2nd ed."},{"key":"2023110714264881900_B73","volume-title":"Dengue: Guidelines for Diagnosis","author":"World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases","year":"2009"},{"issue":"2","key":"2023110714264881900_B74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/514047","article-title":"Early clinical and laboratory indicators of acute dengue illness","volume":"176","author":"Kalayanarooj","year":"1999","journal-title":"J Infect Dis"},{"issue":"1","key":"2023110714264881900_B75","first-page":"105","article-title":"Dengue haemorrhagic fever in children in Delhi","volume":"70","author":"Kabra","year":"1992","journal-title":"Bull World Health Organ"},{"key":"2023110714264881900_B76","unstructured":"Centers for Disease Control and Prevention\n          . Dengue case management for clinicians. Available at: https:\/\/www.cdc.gov\/dengue\/healthcare-providers\/treatment.html. Accessed October 12, 2021"},{"issue":"7","key":"2023110714264881900_B77","first-page":"CD003488","article-title":"Corticosteroids for dengue infection","volume":"2014","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2023110714264881900_B78","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4269\/ajtmh.2007.77.1135","article-title":"Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection","volume":"77","author":"Dimaano","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"2023110714264881900_B79","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000354837","article-title":"Effectiveness of platelet transfusion in dengue fever: a randomized controlled trial","volume":"40","author":"Khan Assir","year":"2013","journal-title":"Transfus Med Hemother"},{"issue":"10079","key":"2023110714264881900_B80","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(17)30269-6","article-title":"Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial","volume":"389","author":"Lye","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"2023110714264881900_B81","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/oxfordjournals.aje.a116487","article-title":"The predisposing and protective factors against dengue virus transmission by mosquito vector","volume":"136","author":"Ko","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2023110714264881900_B82","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3201\/eid2102.140533","article-title":"Use of insecticide-treated house screens to reduce infestations of dengue virus vectors, Mexico","volume":"21","author":"Manrique-Saide","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"2023110714264881900_B83","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3201\/eid2108.150368","article-title":"Underrecognition of dengue during 2013 epidemic in Luanda, Angola","volume":"21","author":"Sharp","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"2023110714264881900_B84","doi-asserted-by":"crossref","first-page":"e0006150","DOI":"10.1371\/journal.pntd.0006150","article-title":"Social-ecological factors and preventive actions decrease the risk of dengue infection at the household-level: results from a prospective dengue surveillance study in Machala, Ecuador","volume":"11","author":"Kenneson","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2023110714264881900_B85","doi-asserted-by":"crossref","first-page":"e0006430","DOI":"10.1371\/journal.pntd.0006430","article-title":"A serologic study of dengue in northwest Ethiopia: suggesting preventive and control measures","volume":"12","author":"Ferede","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2023110714264881900_B86","unstructured":"CDC\n          . 2019. Dengue\u2014prevent mosquito bites. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD). Available at: https:\/\/www.cdc.gov\/dengue\/prevention\/prevent-mosquito-bites.html#:\u223c:text=Use%20air%20conditioning%2C%20if%20available,%2C%20flowerpots%2C%20or%20trash%20containers. Accessed October 10, 2021"},{"issue":"3","key":"2023110714264881900_B87","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4269\/ajtmh.1985.34.625","article-title":"Dengue transmission in two Puerto Rican communities in 1982","volume":"34","author":"Waterman","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"2023110714264881900_B88","doi-asserted-by":"crossref","first-page":"e0003655","DOI":"10.1371\/journal.pntd.0003655","article-title":"A critical assessment of vector control for dengue prevention","volume":"9","author":"Achee","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"2023110714264881900_B89","doi-asserted-by":"crossref","first-page":"e0005625","DOI":"10.1371\/journal.pntd.0005625","article-title":"Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans","volume":"11","author":"Moyes","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2023110714264881900_B90","doi-asserted-by":"crossref","first-page":"e0006822","DOI":"10.1371\/journal.pntd.0006822","article-title":"Alternative strategies for mosquito-borne arbovirus control","volume":"13","author":"Achee","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2023110714264881900_B91","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrmicro2968","article-title":"Beyond insecticides: new thinking on an ancient problem","volume":"11","author":"McGraw","year":"2013","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"2023110714264881900_B92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-6968.2008.01110.x","article-title":"How many species are infected with Wolbachia?--A statistical analysis of current data","volume":"281","author":"Hilgenboecker","year":"2008","journal-title":"FEMS Microbiol Lett"},{"issue":"11","key":"2023110714264881900_B93","doi-asserted-by":"crossref","first-page":"e1797","DOI":"10.1371\/journal.pntd.0001797","article-title":"Open release of male mosquitoes infected with a wolbachia biopesticide: field performance and infection containment","volume":"6","author":"O\u2019Connor","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"2023110714264881900_B94","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/eva.12286","article-title":"Wolbachia strains for disease control: ecological and evolutionary considerations","volume":"8","author":"Hoffmann","year":"2015","journal-title":"Evol Appl"},{"issue":"4","key":"2023110714264881900_B95","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41587-020-0471-x","article-title":"Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populations","volume":"38","author":"Crawford","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"41","key":"2023110714264881900_B96","doi-asserted-by":"crossref","first-page":"e2106828118","DOI":"10.1073\/pnas.2106828118","article-title":"Releasing incompatible males drives strong suppression across populations of wild and Wolbachia-carrying Aedes aegypti in Australia","volume":"118","author":"Beebe","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7361","key":"2023110714264881900_B97","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature10356","article-title":"Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission","volume":"476","author":"Hoffmann","year":"2011","journal-title":"Nature"},{"key":"2023110714264881900_B98","doi-asserted-by":"crossref","first-page":"36","DOI":"10.12688\/gatesopenres.12844.3","article-title":"Scaled deployment of Wolbachia to protect the community from dengue and other Aedes transmitted arboviruses","volume":"2","author":"O\u2019Neill","year":"2019","journal-title":"Gates Open Res"},{"issue":"23","key":"2023110714264881900_B99","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1056\/NEJMoa2030243","article-title":"Efficacy of Wolbachia-infected mosquito deployments for the control of dengue","volume":"384","author":"Utarini","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"2023110714264881900_B100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1590\/S0074-02762010000800002","article-title":"Assessing key safety concerns of a Wolbachia-based strategy to control dengue transmission by Aedes mosquitoes","volume":"105","author":"Popovici","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"2023110714264881900_B101","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals","volume":"215","author":"Henein","year":"2017","journal-title":"J Infect Dis"},{"issue":"3","key":"2023110714264881900_B102","doi-asserted-by":"crossref","first-page":"e0009258","DOI":"10.1371\/journal.pntd.0009258","article-title":"Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)","volume":"15","author":"White","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2023110714264881900_B103","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41467-021-21384-0","article-title":"A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"Nivarthi","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"2023110714264881900_B104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"issue":"13","key":"2023110714264881900_B105","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"2023110714264881900_B106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"issue":"9341","key":"2023110714264881900_B107","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(02)11276-1","article-title":"The future of dengue vaccines","volume":"360","author":"Halstead","year":"2002","journal-title":"Lancet"},{"key":"2023110714264881900_B108","author":"Dengvaxia [package insert]","year":"2019"},{"issue":"1","key":"2023110714264881900_B109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"2023110714264881900_B110","doi-asserted-by":"crossref","first-page":"114918","DOI":"10.1016\/j.diagmicrobio.2019.114918","article-title":"Evaluation of dengue serological tests available in Puerto Rico for identification of prior dengue infection for prevaccination screening","volume":"96","author":"Bonaparte","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"2023110714264881900_B111","doi-asserted-by":"crossref","first-page":"taz078","DOI":"10.1093\/jtm\/taz078","article-title":"Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection","volume":"26","author":"Bonaparte","year":"2019","journal-title":"J Travel Med"},{"issue":"4","key":"2023110714264881900_B112","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(20)30695-2","article-title":"Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials","volume":"21","author":"DiazGranados","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2023110714264881900_B113","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cmi.2019.01.002","article-title":"Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews","volume":"25","author":"Luo","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"2023110714264881900_B114","doi-asserted-by":"crossref","first-page":"e0009557","DOI":"10.1371\/journal.pntd.0009557","article-title":"Target product profile for a dengue pre-vaccination screening test","volume":"15","author":"Fongwen","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"36","key":"2023110714264881900_B115","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1016\/j.vaccine.2019.07.016","article-title":"Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: a meeting report","volume":"37","author":"Wilder-Smith","year":"2019","journal-title":"Vaccine"},{"issue":"5","key":"2023110714264881900_B116","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1473-3099(19)30167-7","article-title":"Sensitivity and negative predictive value for a rapid dengue test","volume":"19","author":"Flasche","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2023110714264881900_B117","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4269\/ajtmh.14-0231","article-title":"Incidence of dengue virus infection in school-aged children in Puerto Rico: a prospective seroepidemiologic study","volume":"92","author":"Arg\u00fcello","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"2023110714264881900_B118","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/trstmh\/try037","article-title":"Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014)","volume":"112","author":"L\u2019Azou","year":"2018","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023110714264881900_B119","article-title":"Dengue vaccine draft recommendations using the evidence to recommendation framework","author":"Paz-Bailey"},{"key":"2023110714264881900_B120","first-page":"ciab864","article-title":"Three years efficacy and safety of Takeda\u2019s dengue vaccine candidate (TAK-003)","author":"Rivera","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"21","key":"2023110714264881900_B121","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"key":"2023110714264881900_B122","unstructured":"Takeda Pharmaceutical Company Limited\n          . Takeda begins regulatory submissions for dengue vaccine candidate in EU and dengue-endemic countries. Available at: https:\/\/www.takeda.com\/newsroom\/newsreleases\/2021\/takeda- begins-regulatory-submissions-for- dengue-vaccine-candidate-in-eu\u2013and- dengue-endemic-countries\/. Accessed October 18, 2021"},{"issue":"42","key":"2023110714264881900_B123","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1016\/j.vaccine.2011.07.023","article-title":"Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine","volume":"29","author":"Durbin","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"2023110714264881900_B124","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/infdis\/jis936","article-title":"A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial","volume":"207","author":"Durbin","year":"2013","journal-title":"J Infect Dis"},{"issue":"330","key":"2023110714264881900_B125","doi-asserted-by":"crossref","first-page":"330ra36","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci Transl Med"},{"key":"2023110714264881900_B126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2020.09.004","article-title":"Dengue vaccine development by the year 2020: challenges and prospects","volume":"43","author":"Wilder-Smith","year":"2020","journal-title":"Curr Opin Virol"},{"issue":"36","key":"2023110714264881900_B127","doi-asserted-by":"crossref","first-page":"E8378","DOI":"10.1073\/pnas.1714250115","article-title":"Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials","volume":"115","author":"Juraska","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2023110714264881900_B128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation [published correction appears in Nat Rev Drug Discov. 2021;20(11):880]","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2023110714264881900_B129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"2023110714264881900_B130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"2023110714264881900_B131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/vaccines9020148","article-title":"mRNA vaccines against flaviviruses","volume":"9","author":"Wollner","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"9853","key":"2023110714264881900_B132","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"issue":"21","key":"2023110714264881900_B133","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-055522\/1559571\/peds_2021055522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-055522\/1559571\/peds_2021055522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:28:06Z","timestamp":1699349286000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/6\/e2021055522\/187012\/Dengue-A-Growing-Problem-With-New-Interventions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":133,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,5,11]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-055522","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"e2021055522"}}